{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-039409","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.166194+00:00","generated_at":"2026-05-16T04:25:17.547234+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Adaptive Biotechnologies Q4 rev $71.7M (+51% YoY); MRD profitable; FY2026 MRD rev guide $255-265M","bullets":["Q4 revenue $71.7M (+51% YoY); FY revenue $277.0M (+55% YoY); net loss narrowed to $13.6M and $59.5M.","MRD segment achieved positive Adjusted EBITDA and cash flow; MRD revenue Q4 $61.9M (+54%), FY $212.3M (+46%).","clonoSEQ test volume Q4 30,038 (+43% YoY); FY 105,587 (+39% YoY); expanded Medicare coverage in mantle cell lymphoma.","Signed two non-exclusive immune receptor data licensing agreements with Pfizer.","FY2026 guidance: MRD revenue $255-265M; total OpEx $350-360M; management expects company-wide profitability in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-039409","json":"https://secwatch.observer/filing/0001193125-26-039409.json","markdown":"https://secwatch.observer/filing/0001193125-26-039409.md","text":"https://secwatch.observer/filing/0001193125-26-039409.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000119312526039409/0001193125-26-039409-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000119312526039409/adpt-20260205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:25:17.547234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}